Efficacy of elbasvir and grazoprevir in participants with hepatitis C virus genotype 4 infection: A pooled analysis
Published 2018 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Efficacy of elbasvir and grazoprevir in participants with hepatitis C virus genotype 4 infection: A pooled analysis
Authors
Keywords
-
Journal
LIVER INTERNATIONAL
Volume -, Issue -, Pages -
Publisher
Wiley
Online
2018-02-22
DOI
10.1111/liv.13727
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Effectiveness of Elbasvir and Grazoprevir Combination, With or Without Ribavirin, for Treatment-Experienced Patients With Chronic Hepatitis C Infection
- (2017) Paul Kwo et al. GASTROENTEROLOGY
- Safety and Efficacy of Elbasvir/Grazoprevir in Patients With Hepatitis C Virus Infection and Compensated Cirrhosis: An Integrated Analysis
- (2017) Ira M. Jacobson et al. GASTROENTEROLOGY
- EASL Recommendations on Treatment of Hepatitis C 2016
- (2017) JOURNAL OF HEPATOLOGY
- Efficacy of a 12-Week Simeprevir Plus Peginterferon/Ribavirin (PR) Regimen in Treatment-Naïve Patients with Hepatitis C Virus (HCV) Genotype 4 (GT4) Infection and Mild-To-Moderate Fibrosis Displaying Early On-Treatment Virologic Response
- (2017) Tarik Asselah et al. PLoS One
- Simple Predictive Model for Identifying Patients with Chronic Hepatitis C and Hepatitis C Virus Genotype 4 Infection with a High Probability of Sustained Virologic Response with Peginterferon Alfa-2a/Ribavirin: Pooled Analysis of Data from Two Large, International Cohort Studies
- (2016) Tarik Asselah et al. ADVANCES IN THERAPY
- Elbasvir–Grazoprevir to Treat Hepatitis C Virus Infection in Persons Receiving Opioid Agonist Therapy
- (2016) Gregory J. Dore et al. ANNALS OF INTERNAL MEDICINE
- Efficacy and safety of elbasvir/grazoprevir and sofosbuvir/pegylated interferon/ribavirin: A phase III randomized controlled trial
- (2016) Jan Sperl et al. JOURNAL OF HEPATOLOGY
- Hepatitis C virus genotype 4: Genotype 1's little brother
- (2016) J. Llaneras et al. JOURNAL OF VIRAL HEPATITIS
- Grazoprevir–Elbasvir Combination Therapy for Treatment-Naive Cirrhotic and Noncirrhotic Patients With Chronic Hepatitis C Virus Genotype 1, 4, or 6 Infection
- (2015) Stefan Zeuzem et al. ANNALS OF INTERNAL MEDICINE
- Hepatitis C Virus
- (2015) Tarik Asselah et al. GASTROENTEROLOGY CLINICS OF NORTH AMERICA
- P0771 : C-SCAPE: Efficacy and safety of 12 weeks of grazoprevir +/- elbasvir +/- ribavirin in patients with HCV GT2, 4, 5 or 6 infection
- (2015) A. Brown et al. JOURNAL OF HEPATOLOGY
- NS5A Sequence Heterogeneity and Mechanisms of Daclatasvir Resistance in Hepatitis C Virus Genotype 4 Infection
- (2015) Nannan Zhou et al. JOURNAL OF INFECTIOUS DISEASES
- Efficacy and safety of 8 weeks versus 12 weeks of treatment with grazoprevir (MK-5172) and elbasvir (MK-8742) with or without ribavirin in patients with hepatitis C virus genotype 1 mono-infection and HIV/hepatitis C virus co-infection (C-WORTHY): a randomised, open-label phase 2 trial
- (2015) Mark Sulkowski et al. LANCET
- Efficacy and safety of grazoprevir (MK-5172) and elbasvir (MK-8742) in patients with hepatitis C virus and HIV co-infection (C-EDGE CO-INFECTION): a non-randomised, open-label trial
- (2015) Jürgen K Rockstroh et al. Lancet HIV
- Correction: The Seroprevalence of Hepatitis C Antibodies in Immigrants and Refugees from Intermediate and High Endemic Countries: A Systematic Review and Meta-Analysis
- (2015) Christina Greenaway et al. PLoS One
- Global distribution and prevalence of hepatitis C virus genotypes
- (2014) Jane P. Messina et al. HEPATOLOGY
- Treatment of Hepatitis C
- (2014) Anita Kohli et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Global epidemiology and genotype distribution of the hepatitis C virus infection
- (2014) Erin Gower et al. JOURNAL OF HEPATOLOGY
- Discovery of MK-8742: An HCV NS5A Inhibitor with Broad Genotype Activity
- (2013) Craig A. Coburn et al. ChemMedChem
- Expanded classification of hepatitis C virus into 7 genotypes and 67 subtypes: Updated criteria and genotype assignment web resource
- (2013) Donald B. Smith et al. HEPATOLOGY
- Hepatitis C virus genotype 4 in Southern and Central Spain does not originate from recent foreign migration waves
- (2013) Federico A. Di Lello et al. JOURNAL OF MEDICAL VIROLOGY
- MK-5172, a Selective Inhibitor of Hepatitis C Virus NS3/4a Protease with Broad Activity across Genotypes and Resistant Variants
- (2012) Vincenzo Summa et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Hepatitis C virus genotype 4d in Southern Italy: Reconstruction of its origin and spread by a phylodynamic analysis
- (2012) Massimo Ciccozzi et al. JOURNAL OF MEDICAL VIROLOGY
- Discovery of MK-5172, a Macrocyclic Hepatitis C Virus NS3/4a Protease Inhibitor
- (2012) Steven Harper et al. ACS Medicinal Chemistry Letters
- IL28B polymorphism is associated with treatment response in patients with genotype 4 chronic hepatitis C
- (2011) Tarik Asselah et al. JOURNAL OF HEPATOLOGY
- Management of hepatitis C virus genotype 4: Recommendations of An International Expert Panel
- (2010) Mahmoud A. Khattab et al. JOURNAL OF HEPATOLOGY
- Injection Drug Use Is a Risk Factor for HCV Infection in Urban Egypt
- (2009) Adela Paez Jimenez et al. PLoS One
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started